Aimz Investment Advisors, LLC Amgen Inc Transaction History

Aimz Investment Advisors, LLC

$289 Million
Q3 2024

A detailed history of Aimz Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 13,365 shares of AMGN stock, worth $3.52 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

13,365

Previous 13,539 1.29%

Holding current value

$3.52 Million

Previous $4.23 Million 1.8%

% of portfolio

1.49%

Previous 1.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $53,832 - $58,704	-174 Reduced 1.29%	13,365 $4.31 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $40,200 - $48,854	-153 Reduced 1.12%	13,539 $4.23 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $113,732 - $137,288	-423 Reduced 3.0%	13,692 $3.89 Million
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $39,889 - $44,999	-156 Reduced 1.09%	14,115 $4.07 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $21,646 - $26,874	-99 Reduced 0.69%	14,271 $3.84 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $428 - $506	2 Added 0.01%	14,370 $3.19 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $16,482 - $20,089	-73 Reduced 0.51%	14,368 $3.47 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $96,879 - $123,097	-423 Reduced 2.85%	14,441 $3.79 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $5,387 - $6,075	-24 Reduced 0.16%	14,864 $3.35 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $15,688 - $17,458	-68 Reduced 0.45%	14,888 $3.62 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $87,269 - $96,542	-398 Reduced 2.59%	14,956 $3.62 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $79,750 - $91,267	401 Added 2.68%	15,354 $3.45 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $5,519 - $6,466	-26 Reduced 0.17%	14,953 $3.18 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $9,810 - $10,883	-42 Reduced 0.28%	14,979 $3.65 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $35,061 - $40,858	-158 Reduced 1.04%	15,021 $3.74 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $216 - $257	1 Added 0.01%	15,179 $3.49 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $43,175 - $48,014	-184 Reduced 1.2%	15,178 $3.86 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $14,440 - $17,720	-73 Reduced 0.47%	15,362 $3.62 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $31,709 - $42,055	-174 Reduced 1.11%	15,435 $3.13 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $66,034 - $84,876	-349 Reduced 2.19%	15,609 $3.76 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $64,768 - $77,606	-372 Reduced 2.28%	15,958 $3.09 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $166 - $195	1 Added 0.01%	16,330 $3.01 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.01%	16,329 $3.1 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $111,856 - $130,572	-627 Reduced 3.7%	16,327 $3.18 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $148,046 - $166,903	-799 Reduced 4.5%	16,954 $3.51 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $16,438 - $18,464	-99 Reduced 0.55%	17,753 $3.28 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $33,547 - $39,204	-198 Reduced 1.1%	17,852 $3.04 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $12,321 - $13,767	-73 Reduced 0.4%	18,050 $3.14 Million
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $167 - $191	1 Added 0.01%	18,123 $3.38 Million
Q2 2017 Aug 15, 2017	BUY	N/A	18,122	18,122 $3.12 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Account

Aimz Investment Advisors, LLC Amgen Inc Transaction History